Tilray Brands, Inc. (TLRY) |
| 9.39 0.09 (0.97%) 01-13 16:00 |
| Open: | 9.37 |
| High: | 9.68 |
| Low: | 9.2 |
| Volume: | 5,218,073 |
| Market Cap: | 996(M) |
| PE Ratio: | -0.4 |
| Exchange: | NASDAQ Global Select |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 15.70 |
| Resistance 1: | 12.41 |
| Pivot price: | 9.50 |
| Support 1: | 7.10 |
| Support 2: | 5.91 |
| 52w High: | 23.2 |
| 52w Low: | 3.5 |
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
| EPS | -24.200 |
| Book Value | 13.820 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.067 |
| Profit Margin (%) | -258.54 |
| Operating Margin (%) | -5.07 |
| Return on Assets (ttm) | -1.7 |
| Return on Equity (ttm) | -85.7 |
Tue, 13 Jan 2026
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings? - Finviz
Mon, 12 Jan 2026
Tilray Brands (NASDAQ:TLRY) Shares Up 1.3% - Still a Buy? - MarketBeat
Mon, 12 Jan 2026
Should Tilray’s Record Q2 Revenue and THC Beverage Push Require Action From Tilray Brands (TLRY) Investors? - simplywall.st
Sat, 10 Jan 2026
International Cannabis Expansion Gives Tilray Positive 2026 Outlook (NASDAQ:TLRY) - Seeking Alpha
Fri, 09 Jan 2026
Tilray Brands (NASDAQ:TLRY) Shares Gap Up - Still a Buy? - MarketBeat
Fri, 09 Jan 2026
Tilray Brands, Inc. (NASDAQ:TLRY) Q2 2026 Earnings Call Transcript - Insider Monkey
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |